OREANDA-NEWS. CV PROTEK, one of the largest Russian pharmaceutical holdings, hold its annual meeting. At this meeting the shareholders decided to pay dividends for the previous period (for 2012 and QI 2013). The total amount of accrued dividends is 2,530 bln. rubles; that are 4.8 rubles per share, taxes included.

It was also decided to elect members of the Board of Directors composing of, as previously appointed: V.S. Yakunin, V.G. Muzyayev, Yu.S. Yakunina, V.N. Gorbunov, A.N. Sukhoruchenko (independent member of the Board), L.M. Sevastyanov (independent member of the Board), and L.R. Novoselsky (independent member of the Board).

Besides, the shareholders approved CV PROTEK annual statement and accounting reports for 2012, appointed the Internal Audit Commission, as well as appointed Baker Tilly RusAudit, OOO as auditor under the Russian Accounting Standards and ZAO PricewaterhouseCoopers Audit, as the IFRS auditor.